Literature DB >> 1955099

Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring.

M Trovati1, S Burzacca, E Mularoni, P Massucco, F Cavalot, L Mattiello, G Anfossi.   

Abstract

The European NIDDM Policy Group states that the lowest target for good control of Type 2 (non-insulin-dependent) diabetic patients is a blood glucose level 4.4 mmol/l, both fasting and postprandially. The aim of this study is to evaluate the occurrence and temporal distribution of values under this target in the clinical records of 463 Type 2 diabetic patients, treated by diet or diet and oral hypoglycaemic agents, monitored for at least 2 years. The protocol includes blood glucose measurements after overnight fasting (08.00 hours), 120-150 min after breakfast (11.00 hours) and 120 and 240 min after lunch (14.00 and 16.00 hours). At least one blood glucose concentration of less than 4.4 mmol/l was presented by 42% of the patients. The only difference between patients showing and not showing glycaemic levels under this target was the higher percentage on oral hypoglycaemic agents in the first group (68.4% vs 56.9%, p = 0.016). We considered 299 blood glucose profiles containing at least one value of less than 4.4 mmol/l, observing that a) 46.9% of profiles from patients treated by diet alone and 68.7% of profiles from patients treated both by diet and oral hypoglycaemic agents presented the lowest blood glucose concentration at 16.00 hours (p = 0.002). b) No correlation existed between fasting blood glucose and values at 16.00 hours in profiles from diet-treated patients, whereas a negative correlation was present in patients on diet and oral hypoglycaemic agents, indicating that an excess of oral agents, administered to correct fasting hyperglycaemia, was the cause of the low glycaemic values in the afternoon.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955099     DOI: 10.1007/bf00400996

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  Plasma oxytocin, arginine vasopressin and atrial natriuretic peptide responses to insulin-induced hypoglycaemia in man.

Authors:  B M Fisher; P H Baylis; B M Frier
Journal:  Clin Endocrinol (Oxf)       Date:  1987-02       Impact factor: 3.478

2.  Does hypoglycaemia aggravate the complications of diabetes?

Authors:  B M Frier; J Hilsted
Journal:  Lancet       Date:  1985-11-23       Impact factor: 79.321

3.  Sulphonylureas and hypoglycaemia.

Authors:  R E Ferner; H A Neil
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

4.  Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.

Authors:  A Matsuda; T Kuzuya; Y Sugita; K Kawashima
Journal:  Horm Metab Res       Date:  1983-09       Impact factor: 2.936

5.  Behaviour of glibenclamide on repeated administration to diabetic patients.

Authors:  L Balant; G R Zahnd; F Weber; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

6.  Role of alpha 2-adrenergic receptor in platelet activation during insulin-induced hypoglycemia in normal subjects.

Authors:  H Kishikawa; H Takeda; S Kiyota; M Sakakida; H Fukushima; K Ichinose; H Matsuda; N Nakamura; H Uzawa
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

7.  Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents.

Authors:  A M Jennings; R M Wilson; J D Ward
Journal:  Diabetes Care       Date:  1989-03       Impact factor: 19.112

8.  Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man.

Authors:  M Trovati; P Massucco; E Mularoni; F Cavalot; G Anfossi; L Mattiello; G Emanuelli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

9.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  3 in total

1.  Self-monitoring of blood glucose in overweight type 2 diabetic patients.

Authors:  D B Muchmore; J Springer; M Miller
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

2.  Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.

Authors:  Franco Cavalot; Andrea Pagliarino; Manuela Valle; Leonardo Di Martino; Katia Bonomo; Paola Massucco; Giovanni Anfossi; Mariella Trovati
Journal:  Diabetes Care       Date:  2011-10       Impact factor: 19.112

Review 3.  Hypoglycaemia in Type 2 diabetes.

Authors:  S A Amiel; T Dixon; R Mann; K Jameson
Journal:  Diabet Med       Date:  2008-01-21       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.